Online Formulary

Drug Status Key

  • On Formulary
  • Specialist Initiation
  • Shared Care
  • Hospital Only
  • Not Recommended

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

13.10.3 Protein kinase C activators

Ingenol mebutate (Picato) has been discontinued due to the risk of skin malignancy. Please see MHRA warning for detail here (pdf)

Expand All / Expand All (incl. cost)

Ingenol mebutate

NICE EMC